Insulin-like growth factor receptor-1 (IGF-IR) as a target for prostate cancer therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10555-013-9482-0.pdf
Reference105 articles.
1. Siegel, R., Naishadham, D., & Jemal, A. (2013). Cancer statistics, 2013. CA: A Cancer Journal for Clinicians, 63, 11–30.
2. Gennigens, C., Menetrier-Caux, C., & Droz, J. P. (2006). Insulin-like growth factor (IGF) family and prostate cancer. Critical Reviews in Oncology/Hematology, 58, 124–145.
3. Kojima, S., Inahara, M., Suzuki, H., Ichikawa, T., & Furuya, Y. (2009). Implications of insulin-like growth factor-I for prostate cancer therapies. International Journal of Urology, 16, 161–167.
4. Baserga, R., Porcu, P., Rubini, M., & Sell, C. (1993). Cell cycle control by the IGF-1 receptor and its ligands. Advances in Experimental Medicine and Biology, 343, 105–112.
5. Adams, T. E., Epa, V. C., Garrett, T. P., & Ward, C. W. (2000). Structure and function of the type 1 insulin-like growth factor receptor. Cellular and Molecular Life Sciences : CMLS, 57, 1050–1093.
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Insulin-like growth factor family and prostate cancer: new insights and emerging opportunities;Frontiers in Endocrinology;2024-05-30
2. miRNAs and related genetic biomarkers according to the WHO glioma classification: From diagnosis to future therapeutic targets;Non-coding RNA Research;2024-03
3. Insulin-like Growth Factor 1 Receptor Expression Correlates with Programmed Death Ligand 1 Expression and Poor Survival in Non-small Cell Lung Cancer;2024-01-09
4. Poly-l-glutamic acid modification modulates the bio-nano interface of a therapeutic anti-IGF-1R antibody in prostate cancer;Biomaterials;2023-10
5. Multi-level functional genomics reveals molecular and cellular oncogenicity of patient-based 3′ untranslated region mutations;Cell Reports;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3